You are here: Industry Insights > UKRI

News List

UK to revolutionise oligonucleotide medicines manufacturing europeanpharmaceuticalreview
February 25, 2021
Collaborators on Grand Challenge 3 will utilise their combined expertise to transform the oligonucleotide supply chain.
UK government pledges £18.5m for long COVID research pharmatimes
February 19, 2021
The UK government has announced it will provide £18.5m to fund research projects aimed at improving understanding of the causes and effects of the longer term effects of COVID-19 – known as long COVID.
India, UK enter into new COVID-19 research partnerships expresspharma
November 02, 2020
A GBP 8-million joint funding initiative will support collaborative research focused on understanding the severity of COVID-19 in South Asian populations in India.
NIHR, UKRI fund eight new coronavirus research projects pharmatimes
September 14, 2020
Eight new research projects investigating the transmission of coronavirus have been awarded a total of £5.3 million by the NIHR and UK Research and Innovation (UKRI), in the hope that findings will help shape COVID-19 policy decisions on prevention and...
University of Sheffield joins UK Coronavirus Immunology Consortium for COVID-19 research expresspharma
August 31, 2020
The Sheffield team will investigate how the body’s immune system responds to infection and also examine how T cells contribute to immunity to the virus to prevent re-infection.
NIHR, UKRI stream £8.4m into coronavirus studies pharmatimes
August 28, 2020
NIHR and UK Research and Innovation (UKRI) are streaming £8.4 million into three new UK-wide research studies aiming to understand immune responses to the novel coronavirus.
UKRI announces six research initiatives into COVID-19 and ethnicity europeanpharmaceuticalreview
July 30, 2020
The UKRI and NIHR will fund projects worth £4.3 million to investigate the disproportionate death rate from COVID-19 among people from BAME backgrounds.
First patient dosed with COVID-19 vaccine using self-amplifying RNA europeanpharmaceuticalreview
June 28, 2020
A Phase I clinical trial to test Imperial College London’s COVID-19 vaccine candidate has been initiated, with the first patient dosed.
NIHR, UKRI call for new COVID-19 research proposals pharmatimes
May 13, 2020
The NIHR and UK Research and Innovation (UKRI) are calling for new research proposals on the risk factors, transmission and prevalence of the COVID-19 virus SARS-CoV-2.
Manufacturing of life-enhancing medicines boosted by new government funding cphi-online
November 27, 2018
Patients could soon receive faster treatment thanks to a multimillion pound government boost to streamline the production of medicines and treatments, including those used to treat blood cancers and inherited disorders.